Disparity on Unplanned Readmission in Melanoma Patients: A National Cancer Database Analysis

Daniel Boczar1, David J Restrepo1, Andrea Sisti1

  • 1Division of Plastic Surgery, Mayo Clinic, Jacksonville, FL, U.S.A.

Anticancer Research
|December 8, 2019
PubMed
Abstract

Insights

Melanoma surgery patients who are non-white or uninsured face higher readmission risks. Factors like invasive tumors and certain locations also increase readmission rates for melanoma patients.

Area of Science:

  • Oncology
  • Surgical Outcomes
  • Health Disparities

Background:

  • Melanoma is a significant public health concern.
  • Hospital readmissions after surgery impact patient outcomes and healthcare costs.
  • Identifying factors associated with readmission is crucial for improving care.

Purpose of the Study:

  • To analyze factors associated with 30-day unplanned hospital readmission after melanoma surgery.
  • To identify patient, tumor, and treatment characteristics that predict readmission risk.

Main Methods:

  • Retrospective analysis of 30-day unplanned readmissions.
  • Utilized data from the National Cancer Database (NCDB).
  • Included patients who underwent surgery for melanoma.

Main Results:

  • Higher readmission odds were observed in non-white patients, uninsured patients, those with invasive tumors, ulceration, advanced AJCC stages (>II), and extremity locations.
  • Lower readmission odds were associated with women in higher income, lower education areas, and treatment at Academic/Research or Integrated Network Cancer Programs.
  • Key predictors of readmission included race, insurance status, tumor invasiveness, and AJCC staging.

Conclusions:

  • Non-white race and low-income zip codes are significant factors associated with unplanned readmission after melanoma surgery.
  • Addressing socioeconomic and racial disparities is essential for reducing melanoma readmission rates.